Tharimmune Inc logo

CNTN

Materials

Tharimmune Inc

$3.20-0.03 (-0.93%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving CNTN Today?

No stock-specific AI insight has been generated for CNTN yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$181M
P/E Ratio
EPS
Dividend Yield
Dividend / Share
ROE
Profit Margin
Debt / Equity

Trading

Volume344K
Avg Volume (10D)
Shares Outstanding56.7M

Price Data

Open$3.20
Previous Close$3.23
Day High$3.25
Day Low$3.13
52 Week High
52 Week Low

About Tharimmune Inc

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

3 employees
Listed January 12, 2022
MaterialsPHARMACEUTICAL PREPARATIONS

Company Details

Security TypeStock
ExchangeNASDAQ
Currency
Round Lot
SICPHARMACEUTICAL PREPARATIONS
CIK
Composite FIGI
Share Class FIGI